Licia Rivoltini

Licia Rivoltini

UNVERIFIED PROFILE

Are you Licia Rivoltini?   Register this Author

Register author
Licia Rivoltini

Licia Rivoltini

Publications by authors named "Licia Rivoltini"

Are you Licia Rivoltini?   Register this Author

100Publications

2632Reads

33Profile Views

Angiogenic and immunological pathways in metastatic renal cell carcinoma: A counteracting paradigm or two faces of the same medal? The GIANUS Review.

Crit Rev Oncol Hematol 2019 Jul 1;139:149-157. Epub 2018 Aug 1.

Unit of Immunotherapy of Human Tumors, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10408428183014
Publisher Site
http://dx.doi.org/10.1016/j.critrevonc.2018.07.009DOI Listing
July 2019

The of a New Way to Value Myeloid Immunosuppression in Cancer.

Cancer Res 2019 Jul;79(13):3169-3171

Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-19-1081DOI Listing
July 2019

Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy.

Virchows Arch 2019 Apr 29;474(4):407-420. Epub 2018 Oct 29.

Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via G. Venezian 1, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00428-018-2477-z
Publisher Site
http://dx.doi.org/10.1007/s00428-018-2477-zDOI Listing
April 2019

Mechanisms of tumor immunotherapy, with a focus on thoracic cancers.

J Thorac Dis 2018 Jul;10(7):4619-4631

Unit of Immunotherapy of Human Tumors, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2018.07.30DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105976PMC
July 2018

Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs.

Cancer Treat Rev 2018 Apr 20;65:78-86. Epub 2018 Mar 20.

Head and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.03.003DOI Listing
April 2018

Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation.

Semin Cancer Biol 2017 04 6;43:74-89. Epub 2017 Mar 6.

Unit of Immunotherapy of Human Tumors, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2017.03.001DOI Listing
April 2017

Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment.

J Invest Dermatol 2017 02 5;137(2):484-493. Epub 2016 Sep 5.

Unit of Immunotherapy of Human Tumors, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2016.06.634DOI Listing
February 2017

Modulation of the myeloid compartment of the immune system by angiogenic- and kinase inhibitor-targeted anti-cancer therapies.

Cancer Immunol Immunother 2015 Jan 4;64(1):83-9. Epub 2014 Jul 4.

Unit of Immunotherapy of Human Tumor, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-014-1576-1
Publisher Site
http://dx.doi.org/10.1007/s00262-014-1576-1DOI Listing
January 2015

Lymphocyte activation gene-3 (LAG-3, CD223) in plasmacytoid dendritic cells (pDCs): a molecular target for the restoration of active antitumor immunity.

Oncoimmunology 2014 Nov 21;3(11):e967146. Epub 2014 Dec 21.

Unit of Immunotherapy of Human Tumors; Dept. of Experimental Oncology and Molecular Medicine; Fondazione IRCCS Istituto Nazionale dei Tumori ; Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/21624011.2014.967146DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292561PMC
November 2014

Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: involvement of LAG-3.

J Invest Dermatol 2014 Jul 17;134(7):1893-1902. Epub 2014 Jan 17.

Unit of Immunotherapy of Human Tumor, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2014.29DOI Listing
July 2014

Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment.

Expert Rev Mol Diagn 2014 Jul 10;14(6):643-6. Epub 2014 Jun 10.

Unit of Immunotherapy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737159.2014.928206DOI Listing
July 2014

Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology.

J Invest Dermatol 2014 May 22;134(5):1389-1396. Epub 2013 Nov 22.

Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA; Research Branch, Sidra Medical and Research Centre, Doha, Qatar. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2013.495DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989423PMC
May 2014

A large de novo 9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma.

BMC Med Genet 2014 May 17;15:59. Epub 2014 May 17.

Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, Milan 20133, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2350-15-59DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036080PMC
May 2014

Immune response markers in sentinel nodes may predict melanoma progression.

Oncoimmunology 2014 15;3:e28498. Epub 2014 Apr 15.

Unit of Immunotherapy; Fondazione IRCCS Istituto Nazionale Tumori; Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.28498DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063153PMC
April 2014

Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression.

Cancer Res 2014 Jan;74(1):130-40

Authors' Affiliations: Immunotherapy Unit; Department of Pathology; Functional Genomics Unit; Immunobiology of Human Tumors Unit; Department of Medical Statistics and University of Milan, Medical Statistics Biometry and Bioinformatics Unit; Department of Surgery, Melanoma and Sarcoma Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan; Microscopy and Image Analysis, University of Milan Bicocca, Milan; Department of Immunohematology and Transfusion Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-1672DOI Listing
January 2014

Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma.

J Transl Med 2013 Sep 27;11:237. Epub 2013 Sep 27.

Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G, Venezian 1, Milan 20133, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-11-237DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856484PMC
September 2013

A variant in FTO shows association with melanoma risk not due to BMI.

Nat Genet 2013 Apr 3;45(4):428-32, 432e1. Epub 2013 Mar 3.

Section of Epidemiology and Biostatistics, Leeds Institute of Molecular Medicine, Leeds Cancer Research UK Centre, St. James's University Hospital, Leeds, UK.

View Article

Download full-text PDF

Source
https://genepi.qimr.edu.au/contents/p/staff/Iles_etal_Nature
Web Search
http://www.nature.com/doifinder/10.1038/ng.2571
Publisher Site
http://dx.doi.org/10.1038/ng.2571DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640814PMC
April 2013

Don't run before you can walk.

Nat Rev Urol 2012 Oct 25;9(10):602. Epub 2012 Sep 25.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2012.103-c1DOI Listing
October 2012

Recent advances on the role of tumor exosomes in immunosuppression and disease progression.

Semin Cancer Biol 2012 Aug 19;22(4):342-9. Epub 2012 Feb 19.

Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2012.02.005DOI Listing
August 2012

Promoter methylation of aminopeptidase N/CD13 in malignant melanoma.

Carcinogenesis 2012 Apr 3;33(4):781-90. Epub 2012 Feb 3.

Institute of Medical Immunology, Martin-Luther-University Halle-Wittenberg, 06112 Halle, Saale, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgs091DOI Listing
April 2012

Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy.

J Cell Physiol 2012 Feb;227(2):658-67

Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS, Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.22773DOI Listing
February 2012

Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients.

Cancer Immunol Immunother 2012 Feb 27;61(2):255-263. Epub 2011 Nov 27.

Unit of Immunotherapy of Human Tumours, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-011-1161-9DOI Listing
February 2012

Defining the critical hurdles in cancer immunotherapy.

Authors:
Bernard A Fox Dolores J Schendel Lisa H Butterfield Steinar Aamdal James P Allison Paolo Antonio Ascierto Michael B Atkins Jirina Bartunkova Lothar Bergmann Neil Berinstein Cristina C Bonorino Ernest Borden Jonathan L Bramson Cedrik M Britten Xuetao Cao William E Carson Alfred E Chang Dainius Characiejus A Raja Choudhury George Coukos Tanja de Gruijl Robert O Dillman Harry Dolstra Glenn Dranoff Lindy G Durrant James H Finke Jerome Galon Jared A Gollob Cécile Gouttefangeas Fabio Grizzi Michele Guida Leif Håkansson Kristen Hege Ronald B Herberman F Stephen Hodi Axel Hoos Christoph Huber Patrick Hwu Kohzoh Imai Elizabeth M Jaffee Sylvia Janetzki Carl H June Pawel Kalinski Howard L Kaufman Koji Kawakami Yutaka Kawakami Ulrich Keilholtz Samir N Khleif Rolf Kiessling Beatrix Kotlan Guido Kroemer Rejean Lapointe Hyam I Levitsky Michael T Lotze Cristina Maccalli Michele Maio Jens-Peter Marschner Michael J Mastrangelo Giuseppe Masucci Ignacio Melero Cornelius Melief William J Murphy Brad Nelson Andrea Nicolini Michael I Nishimura Kunle Odunsi Pamela S Ohashi Jill O'Donnell-Tormey Lloyd J Old Christian Ottensmeier Michael Papamichail Giorgio Parmiani Graham Pawelec Enrico Proietti Shukui Qin Robert Rees Antoni Ribas Ruggero Ridolfi Gerd Ritter Licia Rivoltini Pedro J Romero Mohamed L Salem Rik J Scheper Barbara Seliger Padmanee Sharma Hiroshi Shiku Harpreet Singh-Jasuja Wenru Song Per Thor Straten Hideaki Tahara Zhigang Tian Sjoerd H van Der Burg Paul von Hoegen Ena Wang Marij Jp Welters Hauke Winter Tara Withington Jedd D Wolchok Weihua Xiao Laurence Zitvogel Heinz Zwierzina Francesco M Marincola Thomas F Gajewski Jon M Wigginton Mary L Disis

J Transl Med 2011 Dec 14;9:214. Epub 2011 Dec 14.

Earle A, Chiles Research Institute, Robert W, Franz Research Center, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-9-214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338100PMC
December 2011

Spheres of influence in cancer stem cell biology.

J Invest Dermatol 2011 Feb 21;131(2):546-7. Epub 2010 Oct 21.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2010.305DOI Listing
February 2011

Frequency of circulating Tregs with demethylated FOXP3 intron 1 in melanoma patients receiving tumor vaccines and potentially Treg-depleting agents.

Clin Cancer Res 2011 Feb 21;17(4):841-8. Epub 2010 Dec 21.

Department of Medical Oncology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2227DOI Listing
February 2011

Exploiting liver immunity for the prevention of hepatic metastases.

J Hepatol 2010 Oct 11;53(4):596-8. Epub 2010 Jun 11.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2010.06.001DOI Listing
October 2010

LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites.

J Immunol 2010 Jun 26;184(11):6545-51. Epub 2010 Apr 26.

Unit of Immunotherapy of Human Tumors, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.0903879DOI Listing
June 2010

Proton dynamics in cancer.

J Transl Med 2010 Jun 15;8:57. Epub 2010 Jun 15.

Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-8-57DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905351PMC
June 2010

Multipeptide vaccination in cancer patients.

Expert Opin Biol Ther 2009 Aug;9(8):1043-55

Immuno-biotherapy of Melanoma and Solid Tumors, San Raffaele Foundation Scientific Institute, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712590903085109DOI Listing
August 2009

Modified peptides in anti-cancer vaccines: are we eventually improving anti-tumour immunity?

Cancer Immunol Immunother 2009 Jul 8;58(7):1159-67. Epub 2008 Nov 8.

Unit of Immunotherapy of Human Tumours, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-008-0610-6DOI Listing
July 2009

Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT.

J Invest Dermatol 2009 Jul 22;129(7):1759-68. Epub 2009 Jan 22.

Melanoma Genetics, Department of Experimental Oncology, Immunotherapy of Human Tumors Unit, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2008.422DOI Listing
July 2009

Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.

J Immunol 2009 Mar;182(6):3609-17

Laboratory of Immunology, Regina Elena Cancer Institute Centro della Ricerca Sperimentale, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.0802316DOI Listing
March 2009

Human plasmacytoid dendritic cells interact with gp96 via CD91 and regulate inflammatory responses.

J Immunol 2008 Nov;181(9):6525-35

Unit of Immunotherapy of Human Tumours, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.181.9.6525DOI Listing
November 2008

Human lymphocyte activation gene-3 molecules expressed by activated T cells deliver costimulation signal for dendritic cell activation.

J Immunol 2008 Mar;180(6):3782-8

Unit of Immunotherapy of Human Tumor, Fondazione Instituto di Ricerca e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.180.6.3782DOI Listing
March 2008

Low TCR avidity and lack of tumor cell recognition in CD8(+) T cells primed with the CEA-analogue CAP1-6D peptide.

Cancer Immunol Immunother 2007 Dec 13;56(12):1979-91. Epub 2007 Jun 13.

Unit of Immunotherapy of Human Tumors, IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-007-0342-z
Publisher Site
http://dx.doi.org/10.1007/s00262-007-0342-zDOI Listing
December 2007

Detection of mutated BRAFV600E variant in circulating DNA of stage III-IV melanoma patients.

Int J Cancer 2007 Jun;120(11):2439-44

Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.22598DOI Listing
June 2007

Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.

J Clin Oncol 2007 Jun;25(18):2546-53

Unit of Immunotherapy of Human Tumors and Unit of Medical Statistics and Biometry, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.08.5829DOI Listing
June 2007

Vaccination therapy in prostate cancer.

Cancer Immunol Immunother 2007 Apr 10;56(4):429-45. Epub 2006 Oct 10.

Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-006-0233-8DOI Listing
April 2007

Tumor-released microvesicles as vehicles of immunosuppression.

Cancer Res 2007 Apr;67(7):2912-5

Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-0520DOI Listing
April 2007

Melanoma immunology: past, present and future.

Curr Opin Oncol 2007 Mar;19(2):121-7

Unit of Immunotherapy of Human Tumors, Istituto Nazionale Tumori Foundation, Milan, Italy.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00001622-200703000-000
Publisher Site
http://dx.doi.org/10.1097/CCO.0b013e32801497d7DOI Listing
March 2007

Vaccination: role in metastatic melanoma.

Expert Rev Anticancer Ther 2006 Aug;6(8):1305-18

Istituto Nazionale per lo Studio e la Cura dei Tumori, Unit of Immunotherapy of Human Tumors, Via Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.6.8.1305DOI Listing
August 2006

Heat shock proteins gp96 as immunogens in cancer patients.

Int J Hyperthermia 2006 May;22(3):223-7

Unit of Immunotherapy of Human Tumors, Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/02656730600647957DOI Listing
May 2006

Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells.

Cancer Res 2006 Apr;66(7):3629-38

Department of Drug Research and Evaluation, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-3204DOI Listing
April 2006

T cell responses against tumor associated antigens and prognosis in colorectal cancer patients.

J Transl Med 2005 Jan 19;3(1). Epub 2005 Jan 19.

Medical Department III, Hematology, Oncology, and Transfusion Medicine, Charité University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-3-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC546233PMC
January 2005